Precision Antiplatelet Therapy after Percutaneous Coronary Intervention (Precision PCI) Registry - Informing optimal antiplatelet strategies

• Main Authors: Larisa H. Cavallari (Author), Craig R. Lee (Author), Francesco Franchi (Author), Ellen C. Keeley (Author), Joseph S. Rossi (Author), Cameron D. Thomas (Author), Yan Gong (Author), Caitrin W. McDonough (Author), Petr Starostik (Author), Maryam J. Al Saeed (Author), Latonya Been (Author), Natasha Kulick (Author), Jean Malave (Author), Ian R. Mulrenin (Author), Anh B. Nguyen (Author), Joshua N. Terrell (Author), Grace Tillotson (Author), Amber L. Beitelshees (Author), Almut G. Winterstein (Author), George A. Stouffer (Author), Dominick J. Angiolillo (Author)
• Format: Book
• Published: Wiley, 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor (clopidogrel, prasugrel, or ticagrelor) is indicated after percutaneous coronary intervention (PCI) to reduce the risk of atherothrombotic events. Approximately 30% of the US population has a CYP2C19 no‐function al...